COR - Cencora • Financials

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
09/2016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
09/2023	262,173	3,322	-	0.7%	8.5	522	330%	2,195	0.66	3,787	-458	-2,222	3,328	-1,252	-399	23%	1.1%
09/2024	293,959	3,294	-	0.5%	7.5	646	230%	1,255	0.38	3,337	-487	-2,331	2,850	-1,555	-416	28%	0.93%
09/2025	321,333	3,697	-	0.5%	8	1,508	100%	3,325	0.9	3,727	-668	2,249	3,059	-513	-437	28%	0.72%

To see all financials—including updated, you must be Premium.